Clinical trial Recruiting at 1 site Interventional Ages 18 to 85

Left Bundle Branch Area Pacing vs Right Ventricular Pacing for Atrial Fibrillation Risk in AV Block

Official title: The Impact of Left Bundle Branch Area Pacing Versus Right Ventricular Pacing on the Incidence of New-onset Atrial Fibrillation in Patients With Atrioventricular Block: a Randomized Controlled Trial

Run by Peking Union Medical College Hospital · NCT06023784 · Data updated 2026-11-12

This study tests whether left bundle branch area pacing can lower the chance of developing atrial fibrillation compared with traditional right ventricular pacing in adults with AV block.

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment530 (estimated)
SponsorPeking Union Medical College Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedSeptember 30, 2023
Main results expectedDecember 31, 2028
Study endsDecember 31, 2030
Registry record updatedSeptember 21, 2026
Trial IDNCT06023784 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–85 with AV block requiring ventricular pacing (VP > 40%), including third-degree AV block, certain second-degree blocks, high-grade AV block, or long PR interval, who can consent and commit to 2 years of follow-up.

Probably not a fit

Patients with prior atrial fibrillation, impaired LV function (LVEF < 50%), or conditions preventing follow-up or requiring immediate alternative interventions may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, randomized trial comparing two pacing strategies in adults with AV block. Participants are randomized to receive either left bundle branch area pacing or standard right ventricular pacing. The primary aim is to see if the pacing method influences the incidence of new-onset atrial fibrillation over follow-up. The study excludes patients with prior atrial fibrillation, certain heart conditions, or inability to complete two years of follow-up. Enrollment targets adults aged 18–85 who require ventricular pacing and meet specific AV block criteria.

Why it matters

Potential benefit: If successful, the trial could identify a pacing approach that reduces atrial fibrillation risk for AV block patients.

How similar studies have gone: Prior work in pacing strategies has suggested differential effects on atrial rhythms, but this specific comparison is being evaluated in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients aged 18-85;
* AV block patients with ventricular pacing indications and the expected rate of ventricular pacing(VP)\> 40%, including (a) third-degree AV block; (b) second degree AV block (type II); (c) intermittent advanced AV block with expected VP\>40%; (d) symptomatic first degree AV block and PR interval on ECG \> 300ms;
* Signed informed consent;

Exclusion Criteria:

* Baseline echocardiographic assessment of patients with impaired LV function (LVEF\<50%);
* Patients with the history of atrial fibrillation;
* Having difficulties in follow-up: Those who cannot accept 2-year follow-up on time due to physical condition or other reasons;
* Pacemaker replacement without new implanted ventricular electrodes;
* Surgery is required within 1 year due to severe structural heart disease;
* Patients with tricuspid mechanical valve replacement, or congenital heart disease (including transposition of the great arteries, or permanent left superior vena cava, etc);
* AV block resulting from: (a) Hypertrophic cardiomyopathy(HCM), (b) ventricular septal defect repair, and those who are unlikely to achieve successful LBBAP procedure.

Where it's running

  • Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Comparing two pacemaker pacing methods for AV block

    This trial tests whether conduction system (left bundle branch area) pacing or standard right ventricular pacing works better for people with atrioventricular block who need a permanent pacemaker.

    Recruiting at 2 sites University of Tartu · Tallinn, Harju and 1 other locations · NCT07276490

  • Left bundle branch area pacing with Tendril STS or UltiPace leads

    This study will try left bundle branch area pacing with the Tendril STS or UltiPace lead in adults who need pacemaker leads for bradycardia or related heart conditions to see if pacing and sensing are safe and work through six months after implant.

    Recruiting at 13 sites Abbott Medical Devices · Rio de Janeiro, Rio de Janeiro and 14 other locations · NCT07217392

  • Evaluating different approaches to cardiac pacing in patients

    This study is testing different ways to place pacemakers in adults to see which methods work best and are safest for patients needing heart support.

    Recruiting at 31 sites University Hospital of Ferrara · Ferrara, FE and 30 other locations · NCT06324682

  • Comparing two pacing methods for treating slow heart rates

    This study is testing two different ways to help people with slow heart rates feel better by comparing traditional pacing to a newer method in 2600 patients.

    Recruiting at 45 sites Imperial College London · Dublin and 44 other locations · NCT05815745

  • Comparing Left Bundle Branch Area Pacing to Right Ventricular Pacing in Heart Patients

    This study is testing whether pacing the heart from the left side works better than pacing from the right side for people with slow heartbeats who need help with their heart rhythm.

    Recruiting at 7 sites Yonsei University · Bucheon-si and 7 other locations · NCT05585411

  • AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals

    This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.

    Recruiting at 2 sites Hospital Universitari Vall d'Hebron Research Institute · Leuven and 6 other locations · NCT07924371

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.